Streamlining and Cycle Time Reduction of the Start-up Phase of Clinical Trials

Abstract

Objective: The start-up phase of a clinical trial (CT) plays a vital role in execution of novel drug development. Hence, this study aims to identify the factors responsible for delaying the CT start-up phase. Further, it focuses on streamlining and reducing the cycle time of the start-up phase of newly sponsored CTs. Methodology: Thirteen sponsored CTs conducted (between 2016 and 2017) in clinical research 3 Conclusion: Varied factors are responsible for delay of the start-up phase of CTs and understanding the impact of each factor allows for optimization and faster execution of the start-up phase of CTs.